Methods and compositions for treating malignant tumors associated with kras mutation
US10792299B2 · kind B2 · utility
3Cited by
17References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2017 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Feb 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/344
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides methods and compositions for preventing, treating or ameliorating one or more symptoms of a malignant tumor associated with KRAS mutation in a mammal in need thereof, by identifying a tumor cell in the mammal, the tumor cell comprising at least one of: (i) a mutation of the KRAS gene, and (ii) an aberrant expression level of KRAS protein; and administering to the mammal a therapeutically effective amount of a composition comprising one or more RNAi molecules that are active in reducing expression of GST-π.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.